Amentum Holdings (AMTM) Current Deferred Revenue (2023 - 2026)

On a quarterly basis, Current Deferred Revenue rose 60.71% to $180.0 million in Q2 2026 year-over-year; TTM through Apr 2026 was $180.0 million, a 60.71% increase, with the full-year FY2025 number at $227.0 million, up 100.88% from a year prior.

Amentum Holdings (AMTM) has 4 years of Current Deferred Revenue data on record, last reported at $180.0 million in Q2 2026.

  • Current Deferred Revenue reached $180.0 million in Q2 2026 per AMTM's latest filing, down from $203.0 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for AMTM hit a ceiling of $227.0 million in Q4 2025 and a floor of $112.0 million in Q1 2025.
  • A 4-year average of $155.6 million and a median of $145.0 million in 2024 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: dropped 5.83% in 2024, then skyrocketed 100.88% in 2025.
  • Tracing AMTM's Current Deferred Revenue over 4 years: stood at $120.0 million in 2023, then rose by 19.17% to $143.0 million in 2024, then surged by 58.74% to $227.0 million in 2025, then dropped by 20.7% to $180.0 million in 2026.
  • Business Quant data shows Current Deferred Revenue for AMTM at $180.0 million in Q2 2026, $203.0 million in Q1 2026, and $227.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Relx 81.40 Bn 81.16 Bn -
2 Rentokil Initial 79.56 Bn 78.10 Bn -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 180.00 Mn
Jan 2, 2026 203.00 Mn
Oct 3, 2025 227.00 Mn
Jun 27, 2025 147.00 Mn
Mar 28, 2025 112.00 Mn
Dec 27, 2024 143.00 Mn
Sep 27, 2024 113.00 Mn
Sep 29, 2023 120.00 Mn